SCHEMBL9708813

SCHEMBL9708813

Cc1nc2c(c(=O)n(CC(C)C)c(=O)n2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ADORA3 P0DMS8 2/20 0.42
ADORA1 P30542 2/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
DPP4 P27487 1/20 0.40
LMNA P02545 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MAPK1 P28482 1/20 0.39
BRAF P15056 1/20 0.39
PIK3CG P48736 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CASP1 P29466 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PDE1A P54750 1/20 0.38
PDE1B Q01064 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708624 0.93 PDE1A (0.44) MEN1KMT2ALMNANPSR1TSHR
SCHEMBL9707423 0.92 ADORA3 (0.42) ADORA3ADORA1ADORA2AADORA2B
SCHEMBL9707347 0.91 RAB9A (0.44) RAB9AMEN1KMT2AADORA3ADORA1
SCHEMBL9708258 0.91 MAPT (0.43) MEN1KMT2AADORA3ADORA1ADORA2A
SCHEMBL9708823 0.90 ADORA3 (0.45) RAB9AMEN1KMT2AADORA3ADORA1
SCHEMBL9708497 0.90 RAB9A (0.43) RAB9AMEN1KMT2AADORA3ADORA1
SCHEMBL9708690 0.90 MAPT (0.42) ADORA3ADORA1ADORA2AADORA2BDPP4
SCHEMBL9708429 0.90 ADORA3 (0.40) MEN1KMT2AADORA3ADORA1SMN1; SMN2
SCHEMBL9708711 0.89 ALOX15 (0.46) DPP4LMNANPSR1BRAFMAPT
SCHEMBL9708737 0.89 ADORA3 (0.40) RAB9AADORA3ADORA1ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed